| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1536 |
| Trial ID | NCT02456350 |
| Disease | Lymphoma | Acute Monocytic Leukemia | Chronic Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies |
| Year | 2015 |
| Country | China |
| Company sponsor | Shenzhen Second People's Hospital |
| Other ID(s) | 201504001 |
| Cohort 1 | |||||||||||||
|
|||||||||||||